Not Medicare Enrolled

Dr. Mark Godat, M.D.

Obstetrics & Gynecology · Dallas, TX
7777 FOREST LN STE C218, Dallas, TX 75230
9725666655
Registered in NPPES since 2006
NPI: 1134281405 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Godat from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Godat? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Godat

Dr. Mark Godat is an obstetrics & gynecology specialist in Dallas, TX, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Godat received a total of $28,464 from 72 pharmaceutical and/or device companies across 475 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Godat is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration $28,464 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$28,464
Total received (2018-2024)
Avg $4,066/year across 7 years
Top 3% in TX for obstetrics & gynecology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
72
Companies
475
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,729
2023
$1,691
2022
$1,939
2021
$1,550
2020
$969
2019
$5,559
2018
$15,028

Payments by company (2024)

Amgen Inc.
$302
ABBVIE INC.
$299
Vitrolife Inc.
$181
IDORSIA PHARMACEUTICALS US INC
$156
Astellas Pharma US Inc
$145
Novo Nordisk Inc
$135
MILLICENT US INC
$83
Radius Health, Inc.
$64
Sumitomo Pharma America, Inc.
$44
Organon Llc
$39
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$36
PFIZER INC.
$36
Lilly USA, LLC
$33
Bayer Healthcare Pharmaceuticals Inc.
$31
Amneal Pharmaceuticals LLC
$25
Abbott Laboratories
$25
Davol Inc.
$24
Dexcom, Inc.
$22
ASCEND THERAPEUTICS US, LLC
$19
Minerva Surgical, Inc
$17
Currax Pharmaceuticals LLC
$13
Top 3 companies account for 45.2% of 2024 payments
All-time payments by company (2018-2024) ›
Minerva Surgical, Inc
$11,041
Duchesnay USA Incorporated
$6,808
Amgen Inc.
$1,576
AbbVie Inc.
$815
ABBVIE INC.
$776
Novo Nordisk Inc
$733
AbbVie, Inc.
$629
Radius Health, Inc.
$501
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$452
PFIZER INC.
$399
MILLICENT US INC
$366
IDORSIA PHARMACEUTICALS US INC
$304
Gynesonics, Inc.
$258
AMAG Pharmaceuticals, Inc.
$244
TherapeuticsMD, Inc.
$228
Exeltis, USA Inc.
$193
Biohaven Pharmaceuticals, Inc.
$192
ASCEND THERAPEUTICS US, LLC
$184
Vitrolife Inc.
$181
Synergy Pharmaceuticals Inc
$174
Vertical Pharmaceuticals, LLC
$168
Astellas Pharma US Inc
$164
Amneal Pharmaceuticals LLC
$154
MAYNE PHARMA INC.
$115
Alfasigma USA, Inc.
$104
Pacira Pharmaceuticals Incorporated
$99
MAYNE PHARMA COMMERCIAL LLC
$86
Biohaven Pharmaceutical Holding Company Ltd.
$85
Lilly USA, LLC
$77
Eisai Inc.
$71
Davol Inc.
$65
Lupin Inc.
$63
Bausch Health US, LLC
$61
Vermillion, Inc.
$59
Avion Pharmaceuticals
$59
Agile Therapeutics, Inc.
$55
Allergan, Inc.
$55
Axonics, Inc.
$53
Gemini Laboratories, LLC
$52
Sumitomo Pharma America, Inc.
$44
Organon Llc
$39
Allergan Inc.
$38
Aspira Women's Health Inc
$38
Hologic, LLC
$35
Aesculap, Inc.
$33
Bayer Healthcare Pharmaceuticals Inc.
$31
Innovation Technologies Inc
$30
VIVUS, Inc.
$29
NeuroLogica Corporation, a subsidiary of Samsung Electronics Co., Ltd.
$28
Takeda Pharmaceuticals U.S.A., Inc.
$27
Mission Pharmacal Company
$27
Abbott Laboratories
$25
EISAI INC.
$24
Dexcom, Inc.
$22
IRONWOOD PHARMACEUTICALS, INC
$21
Novum Pharma, LLC
$20
Mycovia Pharmaceuticals, Inc.
$20
Shield Therapeutics Inc
$19
BOSTON SCIENTIFIC CORPORATION
$19
Myovant Sciences Inc.
$19
UROVANT SCIENCES INC
$18
Mylan Pharmaceuticals Inc.
$17
Ironwood Pharmaceuticals, Inc
$17
VistaPharm, Inc.
$16
Invuity, Inc.
$16
Neuronetics, Inc.
$15
Boston Scientific Corporation
$14
KCI USA, Inc
$14
Currax Pharmaceuticals LLC
$13
CooperSurgical, Inc.
$12
Channel Medsystems, Inc.
$12
Solta Medical, a division of Bausch Health US, LLC
$12
Top 3 companies account for 68.2% of all-time payments
Associated products mentioned in payments ›
ABRYSVO · ACCRUFER · ADVANTAGE FIT · ANNOVERA · APLENZIN · ARISTA AH FLEXITIP · ARISTA AH FlexiTip · Alcortin A · Axonics · BOTOX · BYSTOLIC · Balcoltra · Bonjesta · CAIMAN VESSEL SEALERS · CONTRAVE · CitraNatal · DIVIGEL · Dayvigo · Dexcom G6 Transmitter · Diclegis · ESTROGEL · EVENITY · Endometrial Ablation System (Device) · Endosee · Exparel · FEMRING · FORTEO · Femring · GEMTESA · Hera W10 · Humira · IMVEXXY · INTRAROSA · IRRISEPT · Intrarosa · Kyleena · LILETTA · LINZESS · LO LOESTRIN FE · Linzess · Lupron · MAKENA · MYFEMBREE · MyoSure · NEUROSTAR TMS THERAPY · NEXPLANON · NURTEC ODT · Novasure · ORIAHNN · ORILISSA · OVA1 · Orilissa · Osphena · PREMARIN · PREMARIN ORALS · PREVENA · PROCLAIM · Photonblade · Prolia · QSYMIA · QULIPTA · QUVIVIQ · SLYND · SOLOSEC · SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM · SUPRAX · SYNTHROID · Saxenda · Synthroid · TRINTELLIX · TRULANCE · Thyquidity · Trulance · Twirla · Tymlos · UBRELVY · UNITHROID · VIBERZI · VRAYLAR · VYLEESI · Veozah · Vitafol Gummy · Vivjoa · WELLBUTRIN · Wegovy · XIFAXAN · Xulane · ZEPBOUND
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an obstetrics & gynecology specialist in Dallas?
Compare obstetricians & gynecologists in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse obstetricians & gynecologists nearby

Geographic Context

Obstetricians & gynecologists in nearby ZIP areas
665
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
MEDICAL CITY DALLAS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Godat is an obstetrics & gynecology specialist, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Godat receive payments from pharmaceutical companies?
Yes. Dr. Godat received a total of $28,464 from 72 companies across 475 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Godat) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →